Overview
Employees
11-50
Founded date
1996
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 16, 2019 | Venture funds have poured $24.6 billion into proptech so far this year. Deal sizes and the number of funding rounds are expected to keep growing. | Advertisement Venture capital has invested $24.6 billion into built-world tech in 2019 up to Q3, according to a new report by EY and CREtech. The report predicted that 2020 will be the year when category winners will begin to be solidified ... |
| Jan 8, 2017 | NVF Co-leads $26.1M Series A for Cavion | CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Cavion, Inc., announced today the closing of a $26.1 million venture financing. Lilly Ventures and Novartis Venture Fund co-led the investment round in tandem with Enso Ventures and additional particip... |
| Apr 13, 2011 | RTP venture capital climate improved in Q1 but biotechs still clamor for cash | Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems strive to recov... |
| Apr 11, 2011 | U.S. Venture Funds Raised $7.7 Billion In First Quarter, Highest Influx In A Decade | U.S. venture capital firms raised more money last quarter than in any period since 2001. The total raised for new funds was $7.7 billion, according to Dow Jones LP Source. The capital going into VC funds was up 97 percent from a year ago, w... |
| Jun 1, 2010 | NanoPowers Raises CHF5M in Series A Financing | NanoPowers SA, a Lausanne, Switzerland-based medical device company, closed a CHF5m (approximately $4.5m) series A financing. The round was led by seed investors in the company Novartis Venture Funds (NVF), with participation from Initiativ... |
| RTP venture capital climate improved in Q1 but biotechs still clamor for cash | Early stage life science companies still developing their technologies can fall into a gap: too expensive to be supported by more grants or angel investments yet not far enough along to secure venture capital interest. In the worst economy ... |